H.R. 2820 would reauthorize the National Cord Blood Inventory program and the C.W. Bill Young Cell Transplantation program. Those programs support efforts to collect and store blood from umbilical cords and to conduct research and facilitate transplants of bone marrow and blood from umbilical cords. In 2015, more than $33 million was appropriated for these purposes.
Over the 2016-2020 period the bill would authorize the appropriation of $23 million and $30 million per year for the National Cord Blood Inventory program and the C.W. Bill Young Cell Transplantation program, respectively. CBO estimates that implementing the bill would cost $220 million over the 2016-2020 period, assuming appropriation of the authorized amounts. Enacting H.R. 2820 would not affect direct spending or revenues; therefore, pay-as-you-go procedures do not apply.
H.R. 2820 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act.
